|
|
||||||||||
Research Articles |
OBJECTIVE: To review the data generated by studies examining interethnic/racial differences in response to antipsychotics. DATA SOURCES: A MEDLINE search (1966-1996) identified all articles examining differences in antipsychotic response among Caucasians, Asians, Hispanics, and African-Americans, as well as articles evaluating postulated mechanisms for these differences. STUDY SELECTION: All abstracts, studies, and review articles were evaluated. DATA SYNTHESIS: Ethnic/racial differences in response to antipsychotic medications have been reported and may be due to genetics, kinetic variations, dietary or environmental factors, or variations in the prescribing practices of clinicians. Studies suggest that Asians may respond to lower doses of antipsychotics due to pharmacokinetic and pharmacodynamic differences. Research relevant to African-Americans is limited, but some studies suggest that differences in this group may be due to clinician biases and prescribing practices, rather than to pharmacokinetic or pharmacodynamic variability. CONCLUSIONS: Future research directed at validating the hypotheses that different ethnic/racial groups show variations in response to antipsychotics should focus on homogeneous ethnic groups, use recent advances in pharmacogenetic testing, and control for such variables as observer bias, gender, disease chronicity, dietary and environmental factors, and exposure to enzyme-inducing and -inhibiting agents. Clinicians should be aware that potential interethnic/racial differences in pharmacodynamics and pharmacokinetics may exist that can alter response to antipsychotics.
This article has been cited by other articles:
![]() |
M. J. Arranz and S. Kapur Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use? Schizophr Bull, August 27, 2008; (2008) sbn114v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Chaudhry, K. Neelam, V. Duddu, and N. Husain Ethnicity and psychopharmacology J Psychopharmacol, August 1, 2008; 22(6): 673 - 680. [Abstract] [PDF] |
||||
![]() |
J. A. Rey The Interface of Multiculturalism and Psychopharmacology Journal of Pharmacy Practice, December 1, 2006; 19(6): 379 - 385. [Abstract] [PDF] |
||||
![]() |
D. Garver, A. Lazarus, K. Rajagopalan, L. Lamerato, L. M. Katz, L. S. Stern, M. Dolgitser, and J. J. Doyle Racial Differences in Medication Switching and Concomitant Prescriptions in the Treatment of Bipolar Disorder Psychiatr Serv, May 1, 2006; 57(5): 666 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Pi and G. M. Simpson Psychopharmacology: Cross-Cultural Psychopharmacology: A Current Clinical Perspective Psychiatr Serv, January 1, 2005; 56(1): 31 - 33. [Full Text] [PDF] |
||||
![]() |
K. Kim, J. A. Johnson, and H. Derendorf Differences in Drug Pharmacokinetics Between East Asians and Caucasians and the Role of Genetic Polymorphisms J. Clin. Pharmacol., October 1, 2004; 44(10): 1083 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Wang, Z.-J. Zhang,, W.-B. Li, Y.-M. Zhai, Z.-J. Cai, Y.-Z. Weng, R.-H. Zhu, J.-P. Zhao, and H.-H. Zhou The Differential Effects of Steady-State Fluvoxamine on the Pharmacokinetics of Olanzapine and Clozapine in Healthy Volunteers J. Clin. Pharmacol., July 1, 2004; 44(7): 785 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Herbeck, J. C. West, I. Ruditis, F. F. Duffy, D. J. Fitek, C. C. Bell, and L. R. Snowden Variations in Use of Second-Generation Antipsychotic Medication by Race Among Adult Psychiatric Patients Psychiatr Serv, June 1, 2004; 55(6): 677 - 684. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Faison and D. Armstrong Cultural Aspects of Psychosis in the Elderly J Geriatr Psychiatry Neurol, December 1, 2003; 16(4): 225 - 231. [Abstract] [PDF] |
||||
![]() |
G. L. Daumit, R. M. Crum, E. Guallar, N. R. Powe, A. B. Primm, D. M. Steinwachs, and D. E. Ford Outpatient Prescriptions for Atypical Antipsychotics for African Americans, Hispanics, and Whites in the United States Arch Gen Psychiatry, February 1, 2003; 60(2): 121 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Lutz and B. J. Warren Symptomatology and Medication Monitoring for Public Mental Health Consumers: A Cultural Perspective Journal of the American Psychiatric Nurses Association, August 1, 2001; 7(4): 115 - 124. [Abstract] [PDF] |
||||